Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Leblanc

Showing results (51-60 of 95) with videos related to

Pageof 10
Sort By:
Biochimica Et Biophysica Acta|March 15, 1997
Catalytic domain comparisons of human fibroblast-type collagenase, stromelysin-1, and matrilysinL J Windsor, D L Steele, S B LeBlanc, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1984
In vitro activity of WIN 49375 compared with those of other antibiotics in isolates from cancer patientsI Garcia, G P Bodey, V Fainstein, et al.
Revue Du Rhumatisme Et Des Maladies Osteo-Articulaires|October 1, 1980
[Whipple's disease and ankylosing spondylitis]J L Bussière, J L Epifanie, B Leblanc, et al.
The Journal of Antimicrobial Chemotherapy|March 1, 1989
In-vitro activity of PD 117558, a new quinolone against bacterial isolates from cancer patientsK V Rolston, B LeBlanc, G Gooch, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 1, 1988
Comparative in vitro activity of the new difluoro-quinolone temafloxacin (A-62254) against bacterial isolates from cancer patientsK V Rolston, D H Ho, B LeBlanc, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1994
Susceptibilities of bacterial isolates from patients with cancer to levofloxacin and other quinolonesN Dholakia, K V Rolston, D H Ho, et al.
Chemotherapy|September 4, 1999
Susceptibility surveillance among gram-negative bacilli at a cancer centerK Jacobson, K Rolston, L Elting, et al.
La Nouvelle Presse Medicale|March 21, 1981
[Pulmonary arterial hypertension and systemic lupus erythematosus]J L Bussiere, J M Ristori, B Leblanc, et al.
The Journal of Antimicrobial Chemotherapy|October 1, 1987
In-vitro activity of LY146032 against gram-positive isolates from cancer patientsH Saito, K V Rolston, D H Ho, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1992
In vitro activity of Ro 23-9424, a dual-action antibacterial agent, against bacterial isolates from cancer patients compared with those of other agentsK V Rolston, H T Nguyen, D H Ho, et al.
Pageof 10

Showing results (51-60 of 95) with videos related to

Sort By:
Pageof 10
Biochimica Et Biophysica Acta|March 15, 1997
Catalytic domain comparisons of human fibroblast-type collagenase, stromelysin-1, and matrilysinL J Windsor, D L Steele, S B LeBlanc, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1984
In vitro activity of WIN 49375 compared with those of other antibiotics in isolates from cancer patientsI Garcia, G P Bodey, V Fainstein, et al.
Revue Du Rhumatisme Et Des Maladies Osteo-Articulaires|October 1, 1980
[Whipple's disease and ankylosing spondylitis]J L Bussière, J L Epifanie, B Leblanc, et al.
The Journal of Antimicrobial Chemotherapy|March 1, 1989
In-vitro activity of PD 117558, a new quinolone against bacterial isolates from cancer patientsK V Rolston, B LeBlanc, G Gooch, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 1, 1988
Comparative in vitro activity of the new difluoro-quinolone temafloxacin (A-62254) against bacterial isolates from cancer patientsK V Rolston, D H Ho, B LeBlanc, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1994
Susceptibilities of bacterial isolates from patients with cancer to levofloxacin and other quinolonesN Dholakia, K V Rolston, D H Ho, et al.
Chemotherapy|September 4, 1999
Susceptibility surveillance among gram-negative bacilli at a cancer centerK Jacobson, K Rolston, L Elting, et al.
La Nouvelle Presse Medicale|March 21, 1981
[Pulmonary arterial hypertension and systemic lupus erythematosus]J L Bussiere, J M Ristori, B Leblanc, et al.
The Journal of Antimicrobial Chemotherapy|October 1, 1987
In-vitro activity of LY146032 against gram-positive isolates from cancer patientsH Saito, K V Rolston, D H Ho, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1992
In vitro activity of Ro 23-9424, a dual-action antibacterial agent, against bacterial isolates from cancer patients compared with those of other agentsK V Rolston, H T Nguyen, D H Ho, et al.
Pageof 10